Indication
Peyronie's Disease
7 clinical trials
8 products
Clinical trial
Efficacy of a Novel Collagenase Clostridium Histolyticum Protocol for Peyronie's Disease Among Prior Non-responders: A Randomized, Controlled, Single-Blinded StudyStatus: Recruiting, Estimated PCD: 2025-12-20
Product
CCHProduct
Control - CrossoverClinical trial
Impact of Focused Low-intensity Shockwave Therapy (LiSWT) in Penile Disorders (Peyronie's Disease, Erectile Dysfunction, or Both), With or Without Intralesional Clostridial Collagenase (Xiaflex) Injection, Compared With Radial Shock Wave Therapy or Xiaflex TherapyStatus: Withdrawn, Estimated PCD: 2024-12-01
Clinical trial
The Efficacy of Botulinum Toxin Type a in Treating Peyronie's DiseaseStatus: Completed, Estimated PCD: 2017-02-15
Product
Botulinum Toxin Type AProduct
Botulinum Toxin AClinical trial
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional Platelet Rich Plasma for Peyronie's DiseaseStatus: Recruiting, Estimated PCD: 2024-07-15
Clinical trial
Impact of Concurrent Low Intensity Shockwave Therapy on Clinical Outcomes With Collagenase Clostridium Histolyticum in Peyronie's Disease: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Intralesional Injection of Hyaluronic Acid Compared With Verapamil in Peyronie's Disease: A Prospective Randomized Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2024-05-20
Product
Hyaluronic acidProduct
VerapamilClinical trial
Treatment With Stromal Vascular Fraction of Peyronie´s Disease in HumansStatus: Active (not recruiting), Estimated PCD: 2023-12-15
Product
Stromal vascular fraction